UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): | August 25, 2007 |
Lifevantage Corporation
__________________________________________
(Exact name of registrant as specified in its charter)
Colorado | 000-30489 | 90-0224471 |
_____________________ (State or other jurisdiction |
_____________ (Commission |
______________ (I.R.S. Employer |
of incorporation) | File Number) | Identification No.) |
6400 S. Fiddler's Green Circle, Suite 1970, Greenwood Village, Colorado | 80111 | |
_________________________________ (Address of principal executive offices) |
___________ (Zip Code) |
Registrants telephone number, including area code: | 720-488-1711 |
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On August 25, 2007, John Van Heuvelen resigned from his positions as the Chairman and as a member of the Board of Directors of Lifevantage Corporation (f/k/a Lifeline Therapeutics, Inc.) (the "Company"). Mr. Van Heuvelen also resigned as Chairman of the Audit Committee and member of the Compensation and Science Committees of Lifevantage Corporation.
Dr. James D. Crapo, currently a member of the Board of Directors, will serve as the new Chairman of the Board of Directors effective August 25, 2007.
Item 9.01 Financial Statements and Exhibits.
Exhibit 99.1 e-mail dated August 25, 2007 from Mr. John Van Heuvelen to the Board of Directors.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Lifevantage Corporation | ||||
August 27, 2007 | By: |
James J. Krejci
|
||
|
||||
Name: James J. Krejci | ||||
Title: Chief Executive Officer |
Exhibit Index
Exhibit No. | Description | |
|
|
|
1
|
John Van Heuvelen Resignation Email to Board of Directors |